Pharmakea, Inc.
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 24, 2027The maintenance fee for Uses of a Lysyl Oxidase-Like 2 Inhibitor (US 11,793,797) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Fluorinated Lysyl Oxidase-Like 2 Inhibitors and Uses Thereof (US 10,570,094) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof (US 10,588,900) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,150,732 | Fluorinated Lysyl Oxidase-Like 2 Inhibitors and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 10,570,094 | Fluorinated Lysyl Oxidase-Like 2 Inhibitors and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,072,585 | Fluorinated Lysyl Oxidase-Like 2 Inhibitors and Uses Thereof In force · Low confidence | In force | Low confidence | |
| US 11,793,797 | Uses of a Lysyl Oxidase-Like 2 Inhibitor In force · High confidence | In force | High confidence | |
| US 11,358,936 | Lysyl oxidase-like 2 inhibitors and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,588,900 | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,774,069 | Crystalline Forms of a Lysyl Oxidase-Like 2 Inhibitor and Methods of Making In force · High confidence | In force | High confidence | |
| US 11,459,309 | Crystalline Forms of a Lysyl Oxidase-Like 2 Inhibitor and Methods of Making In force · High confidence | In force | High confidence |
Also on record, not counted in the 8: 7 patents in force now held by others · 8 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 abandoned · 6 no status recorded